COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 2282: Articles 22811-22820  | Next

Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction.
Qiang, X., Zhu, S., Li, J., Wang, P., Tracey, K. J., Wang, H.
10.1101/2020.09.04.280081 — Posted: 2020-09-04
Preliminary report of preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates, SK-01 version 1 and OZG-3861 version 1
SIR KARAKUS, G., Tastan, C., Dilek Kancagi, D., Yurtsever, B., Tumentemur, G., Demir, S., Turan, R. D., Abanuz, S., Cakirsoy, D., Seyis, U., Ozer, S., Elibol, O., Elek, M., Ertop, G., Arbak, S., Acikel Elmas, M., Hemsinlioglu, C., Kocagoz, A. S., Hatirnaz Ng, O., Akyoney, S., Sahin, I., Ozbek, U., Telci, D., Sahin, F., Yalcin, K., Ovali, E.
10.1101/2020.09.04.277426 — Posted: 2020-09-04
SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of immune cells
Singh, Y., Trautwein, C., Fendel, R., Krickeberg, N., Held, J., Kreidenweiss, A., Berezhnoy, G., Bissinger, R., Ossowski, S., Salker, M. S., Casadei, N., Riess, O., The DeCOI
10.1101/2020.09.04.282780 — Posted: 2020-09-04 Discussion: Onsite
Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore
Tyson, J. R., James, P., Stoddart, D., Sparks, N., Wickenhagen, A., Hall, G., Choi, J. H., Lapointe, H., Kamelian, K., Smith, A. D., Prystajecky, N., Goodfellow, I., Wilson, S. J., Harrigan, R., Snutch, T. P., Loman, N. J., Quick, J.
10.1101/2020.09.04.283077 — Posted: 2020-09-04
Genomic diversity and evolution of coronavirus (SARS-CoV-2) in France from 309 COVID-19-infected patients
Levasseur, A., Delerce, J., Caputo, A., Brechard, L., Colson, P., Lagier, J.-C., Fournier, P.-E., Raoult, D.
10.1101/2020.09.04.282616 — Posted: 2020-09-04
Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysis
Beressa, T. B., Sahilu, T., Deyno, S.
10.1101/2020.09.03.20187393 — Posted: 2020-09-04 Discussion: Onsite
Multiplexed, Microscale, Microarray-based Serological Assay for Antibodies Against All Human-Relevant Coronaviruses
Dawson, E. D., Kuck, L. R., Blair, R. H., Taylor, A. W., Toth, E., Knight, V., Rowlen, K. L.
10.1101/2020.09.03.20179598 — Posted: 2020-09-04
Clinical Performance Evaluation of a SARS-CoV-2 Rapid Antibody Test for Determining Past Exposure to SARS-CoV-2
Findeisen, P., Stiegler, H., Lopez-Calle, E., Schneider, T., Urlaub, E., Hayer, J., Zemmrich, C. S.
10.1101/2020.09.01.20180687 — Posted: 2020-09-04
Insights into the practical effectiveness of RT-PCR testing for SARS-CoV-2 from serologic data, a cohort study
Zhang, Z., Bi, Q., Fang, S., Wei, L., Wang, X., He, J., Wu, Y., Liu, X., Gao, W., Zhang, R., Su, Q., Azman, A., Lessler, J., Zou, X., Gong, W.
10.1101/2020.09.01.20182469 — Posted: 2020-09-03
The role of masks in reducing the risk of new waves of COVID-19 in low transmission settings: a modeling study
Stuart, R. M., Abeysuriya, R. G., Kerr, C. C., Mistry, D., Klein, D. J., Gray, R., Hellard, M., Scott, N.
10.1101/2020.09.02.20186742 — Posted: 2020-09-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).